EE347 Treatment Patterns and Healthcare Resource Utilization (HRU) Among Patients With Multiple Sclerosis (MS) in Germany Treated With Nabiximols Between 2010 and 2020
Abstract
Authors
J Freilich M Delclaux Rodriguez-Rey S Braune T Spelman S Yeramaneni C Drachenberg